Law: Antitrust Act (New Jersey)

Vascepa monopolisation claims survive motion to dismiss

A New Jersey federal judge has refused to throw out a lawsuit alleging that Amarin Pharma prevented generic competition for the cholesterol-lowering drug Vascepa.

02 March 2023